{"schema_version":"alpha-profile-public-v1","slug":"andrew-oxtoby","canonical_url":"https://registry.alpha.ac/people/andrew-oxtoby","as_of":"2026-09-21T17:50:13.717323+00:00","published_at":"2026-09-02T02:37:20.858414+00:00","last_reviewed_at":"2026-05-01T02:20:52.413+00:00","identity":{"display_name":"Andrew Oxtoby","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive","board"],"current_role":{"company_name":"Kalaris Therapeutics, Inc.","company_slug":"kalaris-therapeutics-inc","exchange":"NASDAQ","ticker":"KLRS","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2025-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","effective_date":"2026-04-24","last_checked_at":"2026-04-24T23:29:01.172+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=andrew-oxtoby","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=andrew-oxtoby&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Andrew Oxtoby has served as President and CEO of Kalaris Therapeutics since the closing of the Merger in March 2025, having previously held the same role at Legacy Kalaris since March 2024. He previously served as Chief Commercial Officer at Chinook Therapeutics and as President and CEO of Aimmune Therapeutics following its acquisition by Nestle Health Science. He spent 16 years at Eli Lilly in various leadership roles and holds a B.S. in Mechanical Engineering from Purdue University and an MBA from Harvard Business School."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Kalaris Therapeutics, Inc.","organizationId":"kalaris-therapeutics-inc","title":"Director","period":"2025-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Kalaris Therapeutics, Inc.","company_slug":"kalaris-therapeutics-inc","exchange":"NASDAQ","ticker":"KLRS","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2025-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","effective_date":"2026-04-24","last_checked_at":"2026-04-24T23:29:01.172+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Andrew Oxtoby as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T02:20:52.636893+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KLRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T02:20:52.507745+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_membership","claim_value":{"ticker":"KLRS","role_type":"Director","organization":"Kalaris Therapeutics, Inc."},"claim_text":"Serves on the board of Kalaris Therapeutics, Inc. as Director.","claim_state":"verified","valid_from":"2025-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:42.999553+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Kalaris Therapeutics, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:45.110153+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Andrew Oxtoby currently serves as Director at Kalaris Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-04-24","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T02:20:52.598693+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KLRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T02:20:52.507745+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":[],"claim_text":"Andrew Oxtoby serves on no disclosed committees.","claim_state":"verified","valid_from":"2026-04-24","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T02:20:52.618501+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KLRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T02:20:52.507745+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Kalaris Therapeutics, Inc.","claim_text":"Andrew Oxtoby is linked to Kalaris Therapeutics, Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T02:20:52.777302+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KLRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T02:20:52.507745+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"President and Chief Executive Officer","claim_text":"Andrew Oxtoby is also listed as President and Chief Executive Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T02:20:52.75903+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KLRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T02:20:52.507745+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Andrew Oxtoby as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T02:20:52.678521+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KLRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T02:20:52.507745+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"director_since","claim_value":{"start_date":null,"director_since":2025},"claim_text":"Director tenure at Kalaris Therapeutics, Inc. begins from 2025.","claim_state":"verified","valid_from":"2025-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:42.999553+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Kalaris Therapeutics, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:45.110153+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"independence_status","claim_value":{"is_independent":false},"claim_text":"Board independence status at Kalaris Therapeutics, Inc.: False.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:42.999553+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Kalaris Therapeutics, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:45.110153+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Andrew Oxtoby as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T02:20:52.656831+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KLRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T02:20:52.507745+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:andrew-oxtoby","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2025-01-01 · current","organization":"Kalaris Therapeutics, Inc.","organization_id":"kalaris-therapeutics-inc"},"claim_text":"Director at Kalaris Therapeutics, Inc. (2025-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/andrew-oxtoby#profile","url":"https://registry.alpha.ac/people/andrew-oxtoby","dateModified":"2026-05-01T02:20:52.413+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/andrew-oxtoby#person","name":"Andrew Oxtoby","url":"https://registry.alpha.ac/people/andrew-oxtoby","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Kalaris Therapeutics, Inc.","tickerSymbol":"NASDAQ: KLRS"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2025-01-01","memberOf":{"@type":"Organization","name":"Kalaris Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/kalaris-therapeutics-inc","tickerSymbol":"NASDAQ: KLRS"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","name":"KLRS DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/andrew-oxtoby"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":1,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":10,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":4,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":1,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":10,"corroborated_claims":1,"sources":4,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-01T02:20:52.413+00:00","observed_at":"2026-09-21T17:50:13.717323+00:00","freshness_days":144}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"andrew-oxtoby","canonical_url":"https://registry.alpha.ac/people/andrew-oxtoby"},"publication":{"published_at":"2026-09-02T02:37:20.858414+00:00","last_reviewed_at":"2026-05-01T02:20:52.413+00:00","as_of":"2026-09-21T17:50:13.717323+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/andrew-oxtoby","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/andrew-oxtoby","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/andrew-oxtoby.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}